These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33913080)

  • 1. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies.
    Mahler M; Kim G; Roup F; Bentow C; Fabien N; Goncalves D; Palterer B; Fritzler MJ; Villalta D
    Immunol Res; 2021 Jun; 69(3):239-248. PubMed ID: 33913080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
    Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
    Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
    Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
    Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
    Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
    Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.
    Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Mahler M; Fritzler MJ; Bossuyt X
    Autoimmun Rev; 2018 Jun; 17(6):533-540. PubMed ID: 29526634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation.
    Keppeke GD; Satoh M; Kayser C; Matos P; Hasegawa T; Tanaka S; Diogenes L; Amaral RQ; Rodrigues SH; Andrade LEC
    Front Immunol; 2022; 13():1011110. PubMed ID: 36225928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
    Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
    J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
    Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
    Clin Exp Rheumatol; 2012; 30(5):748-55. PubMed ID: 22765957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
    Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
    Duran A; Çetin Duran A; Taşkıran İ
    Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong Association of the Myriad Discrete Speckled Nuclear Pattern With Anti-SS-A/Ro60 Antibodies: Consensus Experience of Four International Expert Centers.
    Röber N; Dellavance A; Ingénito F; Reimer ML; Carballo OG; Conrad K; Chan EKL; Andrade LEC
    Front Immunol; 2021; 12():730102. PubMed ID: 34675922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
    Irure-Ventura J; Rodríguez C; Vergara-Prieto E; Vargas ML; Quirant B; Jurado A; Fernández-Pereira L; Martínez-Cáceres E; San José M; López-Hoyos M;
    Rheumatology (Oxford); 2021 Aug; 60(8):3904-3912. PubMed ID: 33437990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population.
    Low AH; Wong S; Thumboo J; Ng SC; Lim JY; Ng X; Earnest A; Fong KY
    Rheumatology (Oxford); 2012 Aug; 51(8):1465-70. PubMed ID: 22491717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.